Literature DB >> 7707074

Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration.

K Tanaka1, M Tanaka, O Onodera, S Igarashi, T Miyatake, S Tsuji.   

Abstract

Passive transfer of paraneoplastic cerebellar degeneration (PCD) IgG to rodents as well as active immunization with recombinant Yo fusion protein were tried in order to examine the roles of anti-Purkinje cell antibody (anti-Yo antibody) present in the sera and cerebrospinal fluid of patients with PCD in Purkinje cell loss, the hall mark of PCD pathology. On a single injection of PCD IgG to mouse brain, IgG was taken into Purkinje cells and remained there for more than 36 h without Purkinje cell loss. Injection of PCD IgG together with complement or lipopolysaccharide-activated human macrophages or rat mononuclear cells to rats ventricles did not cause Purkinje cell loss. We made a recombinant Yo fusion protein that has the leucine-zipper protein (Yo protein), the common epitope for anti-Yo antibody. Mice immunized with this Yo protein produced high titer antibody against it for more than 3 months, during which time neither neurological symptoms nor Purkinje cell loss occurred. The anti-Yo antibody, with or without complement or activated mononuclear cells, therefore could not be the sole cause of Purkinje cell loss.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7707074     DOI: 10.1016/0022-510x(94)90067-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  Neuroinflammation: Ways in Which the Immune System Affects the Brain.

Authors:  Richard M Ransohoff; Dorothy Schafer; Angela Vincent; Nathalie E Blachère; Amit Bar-Or
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 2.  Autoimmune epilepsies.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

3.  Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair L Wood; Ikuo Tsunoda; Noel G Carlson
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

4.  Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.

Authors:  Valentina Damato; Claudia Papi; Gregorio Spagni; Amelia Evoli; Gabriella Silvestri; Gianvito Masi; Eleonora Sabatelli; Lucia Campetella; Andrew McKeon; Francesca Andreetta; Vittorio Riso; Gabriele Monte; Marco Luigetti; Guido Primiano; Paolo Calabresi; Raffaele Iorio
Journal:  Eur J Neurol       Date:  2021-11-09       Impact factor: 6.288

5.  A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.

Authors:  Sven Jarius; Klaus P Wandinger; Sigrun Horn; Heike Heuer; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-03-12       Impact factor: 8.322

6.  [Pathophysiology of antibody-associated diseases of the central nervous system].

Authors:  C G Bien; J Bauer
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 7.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401

Review 8.  Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Keya Adhikari; Daniel Aeschlimann; Partha Chattopadhyay; Marios Hadjivassiliou; Christiane S Hampe; Jérôme Honnorat; Bastien Joubert; Shinji Kakei; Jongho Lee; Mario Manto; Akiko Matsunaga; Hidehiro Mizusawa; Kazunori Nanri; Priya Shanmugarajah; Makoto Yoneda; Nobuhiro Yuki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

Review 9.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

10.  T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

Authors:  Nathalie E Blachère; Dana E Orange; Bianca D Santomasso; Jessica Doerner; Patricia K Foo; Margaret Herre; John Fak; Sébastien Monette; Emily C Gantman; Mayu O Frank; Robert B Darnell
Journal:  Eur J Immunol       Date:  2014-11       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.